Total Prevalence of Mild Cognitive Impairment per 1,000 Among People Aged 65 or Older in 2020 and 2030
Relative Sizes of the Contributing Factors to the Trend in Total Prevalent Cases of Mild Cognitive Impairment over the Next Ten Years
Total Prevalent Cases of Mild Cognitive Impairment by Subtype
Studies Included in the Analysis of Mild Cognitive Impairment
Studies Excluded from the Analysis of Mild Cognitive Impairment
Risk/Protective Factors for Mild Cognitive Impairment
Mariah J. Scott, M.S., M.P.H.,is an associate epidemiologist at Clarivate. Previously, she investigated patient-reported outcomes on health-related quality of life during the transition from pediatric to adult care in patients with Sickle Cell Disease throughout the state of New Jersey. Ms. Scott received her B.S. in Molecular Biology from Montclair State University and her M.S. from Seton Hall University where she studied Microbiology and Immunology. She also holds an M.P.H. degree in epidemiology from Rutgers University.
T.J. Arndt, M.P.H., C.P.H.
Thomas J. Arndt, M.P.H., C.P.H., is a senior epidemiologist at Clarivate. He earned his master’s degree in public health at the University of Florida, where he conducted an internship developing a clinical model for noninvasively screening for nonalcoholic steatohepatitis (NASH). He also holds a B.S. in microbiology and cell science and a B.A. in Spanish, both from the University of Florida. While studying at the University of Florida, Mr. Arndt worked in two physiology-based research labs focusing on maternal and fetal stresses during pregnancy and parturition.